首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Protein kinase C and tyrosine kinase pathways regulate lipopolysaccharide-induced nitric oxide synthase activity in RAW 264.7 murine macrophages.
【2h】

Protein kinase C and tyrosine kinase pathways regulate lipopolysaccharide-induced nitric oxide synthase activity in RAW 264.7 murine macrophages.

机译:蛋白激酶C和酪氨酸激酶途径调节RAW 264.7鼠巨噬细胞中脂多糖诱导的一氧化氮合酶活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. In RAW 264.7 macrophages, lipopolysaccharide (LPS) and gamma-interferon (IFN gamma) alone or in combination stimulated the induction of nitric oxide synthase (iNOS) activity and increased the expression of the 130 kDa isoform of NOS. 2. LPS-induced NOS activity was reduced by incubation with CD14 neutralising antibodies and abolished in macrophages deprived of serum. 3. LPS stimulated a small increase in protein kinase C (PKC) activity in RAW 264.7 macrophages which was dependent on the presence of serum. However, IFN gamma did not potentiate LPS-stimulated PKC activity. 4. The protein kinase C inhibitor, Ro-318220, abolished both LPS- and IFN gamma-stimulated protein kinase C activity and the induction of NOS activity. 5. LPS- and IFN gamma-induced NOS activity was reduced by the tyrosine kinase inhibitor genestein. Genestein also reduced LPS-stimulated protein kinase C activity but did not affect the response to the protein kinase C activator, tetradecanoylphorbol acetate (TPA). 6. Nicotinamide, an inhibitor of poly-ADP ribosylation, abolished LPS- and IFN gamma-induced NOS activity. 7. Brefeldin A, an inhibitor of a factor which stimulates nucleotide exchange activity on the 21 kDa ADP-ribosylation factor, ARF, reduced LPS- and IFN gamma-induced NOS activity by approximately 80%. 8. These results suggest the involvement of protein kinase C, tyrosine kinase and poly-ADP ribosylation pathways in the regulation of the induction of nitric oxide synthase in RAW 264.7 macrophages by LPS and IFN gamma.
机译:1.在RAW 264.7巨噬细胞中,单独或组合使用脂多糖(LPS)和γ-干扰素(IFN gamma)刺激一氧化氮合酶(iNOS)活性的诱导并增加NOS的130 kDa亚型的表达。 2.与CD14中和抗体一起孵育可降低LPS诱导的NOS活性,并在缺乏血清的巨噬细胞中消除。 3. LPS刺激RAW 264.7巨噬细胞中蛋白激酶C(PKC)活性的小幅增加,这取决于血清的存在。但是,γ干扰素不能增强LPS刺激的PKC活性。 4.蛋白激酶C抑制剂Ro-318220废除了LPS和IFNγ刺激的蛋白激酶C活性以及NOS活性的诱导。 5.酪氨酸激酶抑制剂genestein降低了LPS和IFNγ诱导的NOS活性。 Genestein还降低了LPS刺激的蛋白激酶C活性,但不影响对蛋白激酶C激活剂乙酸十四烷酰佛波乙酸酯(TPA)的反应。 6.烟酰胺,一种多ADP核糖基化抑制剂,废除了LPS和IFNγ诱导的NOS活性。 7.布雷菲德菌素A,一种因子的抑制剂,该因子刺激对21kDa ADP-核糖基化因子ARF的核苷酸交换活性,使LPS和IFNγ诱导的NOS活性降低约80%。 8.这些结果表明,蛋白激酶C,酪氨酸激酶和聚ADP核糖基化途径参与了LPS和IFNγ诱导RAW 264.7巨噬细胞中一氧化氮合酶的调控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号